GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 848 filers reported holding GLAXOSMITHKLINE PLC in Q1 2019. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $703,000 | 0.0% | 16,146 | 0.0% | 0.02% | +7.1% |
| Q1 2022 | $703,000 | -1.5% | 16,146 | -0.3% | 0.01% | -12.5% |
| Q4 2021 | $714,000 | +11.9% | 16,200 | -3.0% | 0.02% | +6.7% |
| Q3 2021 | $638,000 | -4.1% | 16,700 | 0.0% | 0.02% | +7.1% |
| Q2 2021 | $665,000 | -20.7% | 16,700 | -28.9% | 0.01% | -26.3% |
| Q1 2021 | $839,000 | -2.6% | 23,500 | +0.4% | 0.02% | -34.5% |
| Q4 2020 | $861,000 | -1.4% | 23,400 | +0.9% | 0.03% | -17.1% |
| Q3 2020 | $873,000 | -7.7% | 23,200 | 0.0% | 0.04% | +2.9% |
| Q2 2020 | $946,000 | +9.0% | 23,200 | +1.3% | 0.03% | -10.5% |
| Q1 2020 | $868,000 | -21.7% | 22,896 | -3.0% | 0.04% | +22.6% |
| Q4 2019 | $1,109,000 | +10.1% | 23,596 | 0.0% | 0.03% | +3.3% |
| Q3 2019 | $1,007,000 | +2.3% | 23,596 | -4.1% | 0.03% | +11.1% |
| Q2 2019 | $984,000 | -3.6% | 24,596 | +0.7% | 0.03% | -3.6% |
| Q1 2019 | $1,021,000 | – | 24,423 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |